Advent France Biotechnology
Investor profile
Venture capital
Deals
4
distinct rounds
Companies
4
backed
Active span
2019–2021
3 yrs
Total round €
€34M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Agomab Therapeutics | Belgium | 1 | €21M |
| Integra Therapeutics | Spain | 1 | €4.5M |
| Arthex Biotech | Spain | 1 | €4.3M |
| Agalaia Therapeutics | France | 1 | €4.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Agomab Therapeutics | Series A | €21M | 2019-03 |
| Integra Therapeutics | Other | €4.5M | 2021-12 |
| Arthex Biotech | Seed | €4.3M | 2020-07 |
| Agalaia Therapeutics | Seed | €4.0M | 2021-09 |